Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maïté Chamourin"'
Autor:
Jerome Galon, Jacques Fieschi, Aurelie Collignon, Alex Trinh, Marion Olive, Maïté Chamourin, Alboukadel Kassambara, Lucie Sudre, Anthony Lebret, Giovanni Bussoti
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/d2d9298d5c7240a39def59423ac5341c
Autor:
Jerome Galon, Aurelie Collignon, Alex Trinh, Marion Olive, Clémence Jaume, Maïté Chamourin, Nour Sfeir, Dylan Anselmo, Raana Ramouz-Charpentier, Georgia Culey, Christophe Haond, Jacques Fieschi-Meric
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/ce515bad97d34972b4d29e0d2c75c7e6
Autor:
Jerome Galon, Aurelie Collignon, Alex Trinh, Marion Olive, Clémence Jaume, Maïté Chamourin, Nour Sfeir, Dylan Anselmo, Raana Ramouz-Charpentier, Georgia Culey, Christophe Haond, Jacques Fieschi-Meric
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/b86738bfef834e5cb4e5ab9c3d5b6147
Autor:
Christophe Haond, Clémence Jaume, Dylan Anselmo, Georgia Culey, Raana Ramouz-Charpentier, Marion Olive, Aurélie Collignon, Nour Sfeir, Jérôme Galon, Maïté Chamourin, Alex Trinh, Jacques Fieschi-Meric
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundCancer immunotherapy reinvigorates tumor-specific T cell responses of CD8+ cytotoxic T lymphocytes that detect intracellular antigens that are presented by MHC class I molecules expressed by all tumor cell types. Because most tumors do not
Autor:
Alex Trinh, Jérôme Galon, Dylan Anselmo, Jacques Fieschi-Meric, Marion Olive, Clémence Jaume, Nour Sfeir, Maïté Chamourin, Christophe Haond, Raana Ramouz-Charpentier, Georgia Culey, Aurélie Collignon
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundDensity and localization of T cells within the tumor microenvironment (TME) is critical to control tumor growth. Immunotherapy with antibodies against immune checkpoint inhibitors (ICI), which aim to reinvigorate exhausted T cells, despite